OPTUS Pharmaceutical Co., Ltd. (KOSDAQ:131030)
5,970.00
+410.00 (7.37%)
At close: Jun 29, 2026
-1.97% (1Y)
| Market Cap | 102.00B +3.7% |
| Revenue (ttm) | 91.62B +11.8% |
| Net Income | 12.70B +39.8% |
| EPS | 796.25 +33.9% |
| Shares Out | 17.65M |
| PE Ratio | 7.26 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 73,333 |
| Open | 5,520.00 |
| Previous Close | 5,560.00 |
| Day's Range | 5,520.00 - 6,000.00 |
| 52-Week Range | 5,440.00 - 20,750.00 |
| Beta | -0.07 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jan 23, 2026 |